hameln pharma ApS — Credit Rating and Financial Key Figures

hameln pharma ApS (CVR number: 39720213) is a company from ALBERTSLUND. The company recorded a gross profit of 6856.8 kDKK in 2024. The operating profit was 6856.8 kDKK, while net earnings were 5288.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 41 %, which can be considered excellent and Return on Equity (ROE) was 53.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 66 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. hameln pharma ApS's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.